Hepion’s mandate is to create beneficial drug therapies to address liver disease including non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). We are open to unique partnering opportunities within this field. To initiate discussions, please contact us or complete the form below.
Hepion Partnership Inquiry
A member of our team will follow-up with you shortly.
Contact Us
Hepion Pharmaceuticals, Inc.
399 Thornall Street, 1st Floor
Edison, NJ 08837
Phone: (732) 902-4000
Fax: (732) 902-4100
info@hepionpharma.com